BIVI Biovie Inc. - 8-K

Item 5.02. Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers.

On November
10, 2025, at the 2025 annual meeting of stockholders (the “Annual Meeting”) of BioVie Inc. ( the
“Company”), the Company’s stockholders approved a n amendment and restatement of the BioVie Inc. 2019 Omnibus
Equity Incentive Plan (the “2019 Plan”), effective November 10, 2025.

The purpose of the 2019 Plan is to help the Company
attract, retain and provide incentives to employees, directors, and consultants of the Company and its affiliates, and to align the interests
of such service providers with those of the Company’s stockholders. The amended and restated 2019 Plan increases the number
of shares of common stock authorized for issuance under the 2019 Plan to 3,100,000 shares, enabling the Company to continue to grant equity
compensation under the 2019 Plan.

The foregoing description of the amended and restated 2019 Plan is
qualified in its entirety by reference to the actual terms of the amended and restated 2019 Plan, a copy of which is attached as Appendix
A to the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on September 25,
2025.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.

Description

10.1

BioVie Inc. 2019 Omnibus Equity Incentive Plan (Amended and Restated through November 10, 2025) (incorporated by reference to Appendix A to the Definitive Proxy Statement on Schedule 14A, filed on September 25, 2025)

104

Cover Page Interactive Data File (embedded within the inline XBRL document)